Pro-Pharmaceuticals Reports Fourth Quarter and Full Year 2007 ... Lifescience-online, Switzerland - Pro-Pharmaceuticals, Inc. (Amex: PRW), a developer of first-in-class, carbohydrate-based targeted therapeutic compounds, today reported its fourth quarter ... |
Comments